StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
11
This year
1
Publishing Date
2024 - 03 - 29
1
2023 - 05 - 15
1
2022 - 12 - 06
1
2022 - 11 - 04
1
2022 - 06 - 10
2
2022 - 03 - 08
1
2022 - 02 - 23
1
2021 - 12 - 13
1
2021 - 12 - 11
1
2021 - 12 - 01
1
Sector
Health technology
11
Producer manufacturing
1
Tags
Antibody
3
Cancer
2
Drug
2
Drug delivery
1
Ema
1
Europe
2
Fda
1
Global
2
Growing
1
Growth
1
Leukemia
1
Liver
1
Market
3
N/a
7
People
1
Pharm-country
1
Report
3
Research
1
Results
2
Therapeutics
1
Therapy
1
Treatment
1
Entities
3m company
8
Abbott laboratories
37
Abbvie inc.
165
Abcam plc
7
Abeona therapeutics inc.
7
Adaptimmune therapeutics plc
9
Adc therapeutics sa
8
Agios pharmaceuticals, inc.
12
Alibaba group holding limited
7
Alico, inc.
7
Alnylam pharmaceuticals, inc.
11
Amgen inc.
742
Astellas pharma inc
31
Astrazeneca plc
106
Aveo pharmaceuticals, inc.
10
Bausch health companies inc.
19
Baxter international inc.
22
Becton, dickinson and company
9
Beigene, ltd.
117
Biocryst pharmaceuticals, inc.
13
Biogen inc.
49
Biomarin pharmaceutical inc.
8
Blueprint medicines corporation
12
Bristol-myers squibb company
86
Chemocentryx, inc.
51
Clovis oncology, inc.
10
Credit suisse group
8
Credit suisse group ag
8
Eli lilly and company
88
Entera bio ltd.
35
Epizyme, inc.
10
Exelixis, inc.
12
Genmab a/s
11
Gilead sciences, inc.
35
Glaxosmithkline plc
110
Illumina, inc.
15
Incyte corporation
12
Intel corporation
8
Johnson & johnson
94
Karyopharm therapeutics inc.
12
Medtronic plc
17
Morgan stanley
10
Norfolk southern corporation
10
Novartis ag
196
Novo nordisk a/s
17
Omeros corporation
14
Orchard therapeutics plc
8
Otonomy, inc.
14
Pfizer, inc.
34
Regeneron pharmaceuticals, inc.
27
Rigel pharmaceuticals, inc.
11
Sanofi
170
Takeda pharmaceutical company limited
23
Teva pharmaceutical industries ltd
83
Thermo fisher scientific inc
21
Ucb s.a.
10
Verastem, inc.
10
Viatris inc.
37
Xeris pharmaceuticals, inc.
11
Y-mabs therapeutics, inc.
11
Symbols
ABBV
30
ADCT
8
ALPMF
1
ALPMY
1
AMGN
11
ARGX
2
ARVN
1
ATRS
1
AVTR
1
AZN
2
AZNCF
2
BDX
1
BHC
1
BIIB
1
BMRN
2
BMY
6
BNTX
8
BOLT
4
CERE
2
CVAC
2
DHR
1
FLIDF
3
FLIDY
3
FNCTF
2
FRBA
18
GERN
1
GILD
4
GLAXF
5
GMAB
297
GNMSF
225
GRMN
1
GRNA
2
GSK
7
HALO
4
ICLR
1
IFNNF
1
IFNNY
1
IMNM
1
JAZZ
2
JNJ
57
KRTX
1
LGND
1
LLY
2
MDT
1
MEDE
1
MELI
1
MMM
1
MRTX
1
MS
6
NTLA
3
NVO
4
NVS
21
NVSEF
12
OBSV
2
PFE
4
SGEN
17
SNY
11
SNYNF
10
TAK
3
ZLAB
3
Exchanges
Nasdaq
11
Nyse
11
Crawled Date
2024 - 03 - 29
1
2023 - 05 - 15
1
2022 - 12 - 06
1
2022 - 11 - 04
1
2022 - 06 - 10
2
2022 - 03 - 08
1
2022 - 02 - 23
1
2021 - 12 - 14
1
2021 - 12 - 11
1
2021 - 12 - 01
1
Crawled Time
01:00
1
11:00
1
13:00
2
17:00
2
18:00
3
20:20
1
21:00
1
Source
www.biospace.com
4
www.prnewswire.com
7
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Genmab a::S
symbols :
Amgn
save search
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published:
2024-03-29
(Crawled : 18:00)
- prnewswire.com
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
Email alert
Add to watchlist
GMAB
|
$28.72
1.38%
1.36%
360K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
GNMSF
|
$290.38
3.83%
220
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
research
global
leukemia
therapeutics
market
Targeted Therapy Global Market Report 2023: Increasing Prevalence of Cancer Drives Growth
Published:
2023-05-15
(Crawled : 17:00)
- prnewswire.com
GNMSF
|
$290.38
3.83%
220
|
Health Technology
|
-32.3%
|
O:
0.24%
H:
0.66%
C:
0.66%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
7.89%
|
O:
-1.1%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-19.17%
|
O:
0.61%
H:
0.3%
C:
0.24%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-8.51%
|
O:
0.2%
H:
0.13%
C:
-0.22%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
8.81%
|
O:
0.27%
H:
0.6%
C:
0.41%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-14.4%
|
O:
0.38%
H:
0.0%
C:
0.0%
GMAB
|
$28.72
1.38%
1.36%
360K
|
Health Technology
|
-31.16%
|
O:
0.38%
H:
0.91%
C:
0.69%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
15.45%
|
O:
0.14%
H:
0.28%
C:
0.11%
report
cancer
global
therapy
growth
market
Medikine Appoints Roland Buelow, Ph.D., to Board of Directors
Published:
2022-12-06
(Crawled : 17:00)
- biospace.com/
GNMSF
|
$290.38
3.83%
220
|
Health Technology
|
-37.61%
|
O:
-0.15%
H:
1.16%
C:
-0.9%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-17.27%
|
O:
0.64%
H:
0.04%
C:
-2.12%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
1.51%
|
O:
0.05%
H:
0.22%
C:
-0.19%
SGEN
|
$228.74
0.1%
20M
|
Health Technology
|
88.7%
|
O:
-0.49%
H:
0.12%
C:
-2.25%
LGND
|
$72.59
0.1%
0.1%
140K
|
Health Technology
|
3.97%
|
O:
0.3%
H:
0.0%
C:
-2.98%
GMAB
|
$28.72
1.38%
1.36%
360K
|
Health Technology
|
-37.66%
|
O:
0.11%
H:
0.02%
C:
-1.74%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
0.19%
|
O:
-0.48%
H:
1.59%
C:
0.69%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-5.61%
|
O:
0.33%
H:
0.56%
C:
-0.89%
Cancer Monoclonal Antibodies Market Report 2022: Rising Preference for Personalized Medicines Provides Boost to Sector
Published:
2022-11-04
(Crawled : 18:00)
- prnewswire.com
GNMSF
|
$290.38
3.83%
220
|
Health Technology
|
-28.27%
|
O:
-2.57%
H:
3.43%
C:
2.04%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
41.88%
|
O:
2.28%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
17.39%
|
O:
1.13%
H:
0.63%
C:
0.53%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-12.95%
|
O:
0.38%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
21.04%
|
O:
1.25%
H:
0.03%
C:
-0.78%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
100.82%
|
O:
0.97%
H:
0.18%
C:
-2.13%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-37.65%
|
O:
0.42%
H:
0.59%
C:
-0.04%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
15.23%
|
O:
0.64%
H:
0.16%
C:
-0.05%
GMAB
|
$28.72
1.38%
1.36%
360K
|
Health Technology
|
-27.06%
|
O:
0.58%
H:
0.93%
C:
0.93%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
1.15%
|
O:
-1.48%
H:
2.81%
C:
2.71%
report
cancer
market
Janssen Presents Updated Results Evaluating First-in-Class GPRC5D Bispecific Antibody Talquetamab in Heavily Pretreated Patients with Multiple Myeloma
Published:
2022-06-10
(Crawled : 13:00)
- biospace.com/
GNMSF
|
$290.38
3.83%
220
|
Health Technology
|
-4.59%
|
O:
-4.41%
H:
3.01%
C:
0.79%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-16.45%
|
O:
-2.85%
H:
0.0%
C:
0.0%
GMAB
|
$28.72
1.38%
1.36%
360K
|
Health Technology
|
-5.9%
|
O:
-5.18%
H:
0.0%
C:
0.0%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
9.52%
|
O:
-2.34%
H:
0.0%
C:
0.0%
antibody
results
Janssen Presents Updated Data at EHA for Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma
Published:
2022-06-10
(Crawled : 13:00)
- biospace.com/
GNMSF
|
$290.38
3.83%
220
|
Health Technology
|
-4.59%
|
O:
-4.41%
H:
3.01%
C:
0.79%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-16.45%
|
O:
-2.85%
H:
0.0%
C:
0.0%
GMAB
|
$28.72
1.38%
1.36%
360K
|
Health Technology
|
-5.9%
|
O:
-5.18%
H:
0.0%
C:
0.0%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
9.52%
|
O:
-2.34%
H:
0.0%
C:
0.0%
Hematological Malignancies Drugs Market worth $ 42.78 Billion by 2030 - Exclusive Report by InsightAce Analytic
Published:
2022-03-08
(Crawled : 11:00)
- prnewswire.com
GNMSF
|
$290.38
3.83%
220
|
Health Technology
|
-8.38%
|
O:
-0.14%
H:
5.36%
C:
5.36%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-11.08%
|
O:
-2.75%
H:
0.28%
C:
-1.04%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-12.14%
|
O:
1.89%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
0.08%
|
O:
0.38%
H:
1.81%
C:
0.28%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-29.09%
|
O:
-1.55%
H:
0.71%
C:
-0.28%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
12.01%
|
O:
0.29%
H:
0.6%
C:
-1.24%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.18%
|
O:
3.03%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
12.39%
|
O:
1.4%
H:
0.7%
C:
-1.15%
GMAB
|
$28.72
1.38%
1.36%
360K
|
Health Technology
|
-9.76%
|
O:
-0.3%
H:
3.38%
C:
0.32%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
16.15%
|
O:
0.35%
H:
0.0%
C:
0.0%
ema
drug
report
Worldwide Drug Delivery Industry to 2027 - Growing Focus Towards Home Care and Self-Administration Presents Opportunities
Published:
2022-02-23
(Crawled : 18:00)
- prnewswire.com
GNMSF
|
$290.38
3.83%
220
|
Health Technology
|
-7.01%
|
O:
5.23%
H:
0.0%
C:
-0.34%
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-3.63%
|
O:
-0.48%
H:
3.79%
C:
3.12%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
13.22%
|
O:
1.68%
H:
0.0%
C:
-1.1%
WST
|
$372.04
-1.4%
0.0%
440K
|
Health Technology
|
0.79%
|
O:
0.24%
H:
0.24%
C:
-3.38%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
9.94%
|
O:
1.82%
H:
0.07%
C:
-1.0%
MDT
|
$79.48
0.37%
-0.29%
6.7M
|
Health Technology
|
-23.37%
|
O:
0.5%
H:
0.25%
C:
-1.16%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.21%
|
O:
0.23%
H:
0.7%
C:
-0.18%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-6.89%
|
O:
1.9%
H:
0.07%
C:
-0.87%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
203.73%
|
O:
0.59%
H:
0.89%
C:
-0.93%
BDX
|
$234.12
0.42%
0.0%
1.3M
|
Health Technology
|
-11.37%
|
O:
0.22%
H:
1.9%
C:
1.48%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
14.32%
|
O:
0.45%
H:
1.46%
C:
0.37%
MMM
|
$92.27
0.86%
-0.18%
3.6M
|
Producer Manufacturing
|
-37.12%
|
O:
0.0%
H:
0.4%
C:
-1.61%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-11.1%
|
O:
2.09%
H:
0.08%
C:
-1.22%
GMAB
|
$28.72
1.38%
1.36%
360K
|
Health Technology
|
-7.87%
|
O:
1.06%
H:
0.0%
C:
-1.67%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
12.73%
|
O:
1.43%
H:
0.0%
C:
-1.85%
ATRS
|
$5.59
0.0%
|
Health Technology
|
62.03%
|
O:
0.29%
H:
0.87%
C:
-2.6%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
21.46%
|
O:
0.57%
H:
0.48%
C:
-0.75%
drug
liver
growing
drug delivery
New Data from MajesTEC-1 Study Show Continued Deep and Durable Responses of Teclistamab (BCMAxCD3 Bispecific Antibody) in Treatment of Heavily Pretreated Patients with Multiple Myeloma
Published:
2021-12-13
(Crawled : 01:00)
- prnewswire.com
GNMSF
|
$290.38
3.83%
220
|
Health Technology
|
-23.53%
|
O:
-3.62%
H:
5.16%
C:
4.16%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-10.4%
|
O:
1.9%
H:
0.0%
C:
0.0%
GMAB
|
$28.72
1.38%
1.36%
360K
|
Health Technology
|
-24.79%
|
O:
-4.01%
H:
1.01%
C:
-2.07%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
27.55%
|
O:
0.22%
H:
1.65%
C:
1.15%
treatment
antibody
Janssen Presents Updated Results Evaluating First-in-Class Talquetamab (GPRC5DxCD3 Bispecific Antibody) in Heavily Pretreated Patients with Multiple Myeloma
Published:
2021-12-11
(Crawled : 20:20)
- prnewswire.com
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
GNMSF
|
$290.38
3.83%
220
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
Email alert
Add to watchlist
GMAB
|
$28.72
1.38%
1.36%
360K
|
Health Technology
|
Email alert
Add to watchlist
results
antibody
U.S. FDA Approves DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in Combination with Carfilzomib and Dexamethasone for Patients with Multiple Myeloma After First or Subsequent Relapse
Published:
2021-12-01
(Crawled : 21:00)
- biospace.com/
GNMSF
|
$290.38
3.83%
220
|
Health Technology
|
-25.33%
|
O:
-0.54%
H:
3.8%
C:
2.35%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.69%
|
O:
-1.03%
H:
2.04%
C:
0.76%
GMAB
|
$28.72
1.38%
1.36%
360K
|
Health Technology
|
-25.49%
|
O:
0.55%
H:
0.59%
C:
-1.88%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
35.22%
|
O:
0.78%
H:
2.59%
C:
0.18%
fda
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
UONE
|
$2.36
19.8%
16.53%
75K
|
Consumer Services
RWOD
|
$9.54
19.3%
16.18%
6.1M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.